Literature DB >> 18827368

High dosage sildenafil induces hearing impairment in mice.

Bin Na Hong1, Tae Hoo Yi, Sun Yeou Kim, Tong Ho Kang.   

Abstract

Sildenafil is widely administered for the treatment of erectile dysfunction. Recently, sensorineural hearing loss following the ingestion of sildenafil was reported in one male patient. We examined hearing in mice that were administered high doses of sildenafil for up to 105 d. To assess hearing impairment, we evaluated auditory brainstem responses, auditory middle latency responses, and otoacoustic emissions. At high doses, sildenafil increased the hearing threshold shift of auditory brainstem responses. High-dose sildenafil treatment also resulted in delayed latency of both auditory brainstem responses and auditory middle responses. Otoacoustic emissions differed between control and high-dose sildenafil groups with long-term treatment. Collectively, these data demonstrate that high-dose and long-term sildenafil administration can induce hearing impairment in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827368     DOI: 10.1248/bpb.31.1981

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.

Authors:  Mirko Jaumann; Juliane Dettling; Martin Gubelt; Ulrike Zimmermann; Andrea Gerling; François Paquet-Durand; Susanne Feil; Stephan Wolpert; Christoph Franz; Ksenya Varakina; Hao Xiong; Niels Brandt; Stephanie Kuhn; Hyun-Soon Geisler; Karin Rohbock; Peter Ruth; Jens Schlossmann; Joachim Hütter; Peter Sandner; Robert Feil; Jutta Engel; Marlies Knipper; Lukas Rüttiger
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

Review 2.  A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy.

Authors:  Samuel L Washington; Alan W Shindel
Journal:  Drug Des Devel Ther       Date:  2010-09-07       Impact factor: 4.162

3.  Ups and downs of Viagra: revisiting ototoxicity in the mouse model.

Authors:  Adrian Au; John Gerka Stuyt; Daniel Chen; Kumar Alagramam
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

Review 4.  Phosphodiesterase type 5 inhibitors and sudden sensorineural hearing loss.

Authors:  Monique Antunes de Souza Chelminski Barreto; Fayez Bahmad
Journal:  Braz J Otorhinolaryngol       Date:  2013 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.